News
Early Screening for Schizophrenia and the Opportunity of LAIs
3+ hour, 27+ min ago (426+ words) Early psychosis screening in teens and young adults helps catch overlooked symptoms sooner. Psychiatric Times: We know schizophrenia tends to develop earlier in life; can you share why early screening is so important for schizophrenia and psychosis?2 PT: When working…...
OCD, Psychedelics, and Cannabinoids: New Evidence
1+ week, 6+ day ago (164+ words) Amidst the resurgence in psychedelics research, a new study evaluated the potential of psychedelics like psilocybin, as well as cannabinoids, to treat obsessive-compulsive disorder. Investigators found potential in psilocybin, but no strong evidence supporting cannabinoids as treatment. Psychiatric Times discussed…...
A Digital Therapeutic (CT-152) as Adjunct To Antidepressant Medication: A Phase 3 Randomized Controlled Trial (the Mirai study) | Psychiatric Times
2+ week, 22+ hour ago (1144+ words) So Desiree, we still have a big problem with treating depressed patients. We have at least two major unmet needs, it seems to be. One is that people can't get access to care, and even if they can get the…...
Presenting Our February 2026 Theme: Bipolar Disorder
3+ week, 2+ day ago (156+ words) Explore insights on bipolar disorder, including suicide risk assessment and comorbidities. Share your insights and experiences today with our February theme! Psychiatric Times features monthly themes that speak to various aspects of psychiatry and issues relevant to psychiatric clinicians. Our…...
One Year After the President’s Inauguration
3+ week, 6+ day ago (408+ words) One Year After the President's Inauguration'Psychiatric Times This video series is taking a short break while Dr Moffic travels. For now, enjoy the rerun of this video with updated commentary. It would be hard to deny that this past year…...
Treating Inflammation to Relieve Depression, Anhedonia
4+ week, 22+ hour ago (513+ words) Anti-inflammatory treatment was found to reduce depressive symptoms and anhedonia in selected patients, in a meta-analysis of controlled trials with cohorts exhibiting an inflammatory phenotype.1 Mac Giollabhui discussed the utility of CRP levels in identifying inflammatory phenotype among individuals with…...
New Phase 3 Data Analysis: Lumateperone Shows Promise for Remission of Major Depressive Disorder
1+ mon, 1+ week ago (361+ words) New Phase 3 Data Analysis: Lumateperone Shows Promise for Remission of Major Depressive Disorder'Psychiatric Times Johnson & Johnson has announced a new analysis of phase 3 data which found lumateperone (Caplyta), in combination with an antidepressant, showed significantly greater remission rates in adults…...
A Network-Based Approach to Depression, Neuropathic Pain, and Substance Use Disorder Using Coadministered TMS and Ketamine
1+ mon, 1+ week ago (220+ words) Salience network (anterior cingulate cortex [ACC], anterior insula): coordinates the brain's response to salient emotional and somatic stimuli. Hyperactivity is linked to pain amplification and emotional reactivity. Case series and real-world clinical reports support the efficacy of this strategy, with…...
In Memoriam, Epilogue: The Psychiatrist Who Mistook Oliver Sacks for a Psychiatrist Confesses
1+ mon, 1+ week ago (488+ words) Exploring the complex legacy of Oliver Sacks, this article examines the blurred lines between truth and fiction in his case studies. PSYCHIATRIC VIEWS ON THE DAILY NEWS Yesterday, I wrote my catch-up column on psychiatrists who passed away in 2025 that…...
Progress Report: Second Interim Safety Review of Phase 3 Trial of LPCN 1154 in Postpartum Depression
1+ mon, 1+ week ago (305+ words) Lipocine's LPCN 1154 shows promise in treating postpartum depression, with a strong safety profile and potential for rapid relief in outpatient settings. Lipocine today announced the completion of a scheduled independent Data Safety Monitoring Board (DSMB) review of its ongoing phase…...